PET and functional anatomic fusion imaging in lung and breast cancers

被引：0

作者：

Görres, GW ^{[1
]}

Steinert, HC ^{[1
]}

von Schulthess, GK ^{[1
]}

机构：

[1] Univ Zurich Hosp, Div Nucl Med, CH-8091 Zurich, Switzerland

来源：

CANCER JOURNAL | 2004年 / 10卷 / 04期

关键词：

PET-CT; image fusion; lung cancer; breast cancer; (IF)-I-18-FDG;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Metabolic imaging with PET is an established adjunct to anatomic imaging methods in patients with bronchial and breast cancers. The functional anatomic fusion imaging with PET/CT can further improve staging and restaging of patients. PET/CT can influence the planning of a surgical intervention or radiation treatment at staging and in patients with suspected locoregional recurrence. The use of a PET/CT whole body imaging protocol may identify extended disease earlier than conventional imaging methods and thus influence treatment decisions.

引用

页码：251 / 261

页数：11

共 49 条

[1] Axillary lymph node metastases: Screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET [J].

Adler, LP ;

Faulhaber, PF ;

Schnur, KC ;

AlKasi, NL ;

Shenk, RR .

RADIOLOGY, 1997, 203 (02) :323-327

[2] EVALUATION OF BREAST MASSES AND AXILLARY LYMPH-NODES WITH [F-18] 2-DEOXY-2-FLUORO-D-GLUCOSE PET [J].

ADLER, LP ;

CROWE, JP ;

ALKAISI, NK ;

SUNSHINE, JL .

RADIOLOGY, 1993, 187 (03) :743-750

[3] Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients [J].

Ahmad, A ;

Barrington, S ;

Maisey, M ;

Rubens, RD .

BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) :478-482

[4] Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)fluoro-2-deoxy-D-glucose [J].

Avril, N ;

Dose, J ;

Janicke, F ;

Ziegler, S ;

Romer, W ;

Weber, W ;

Herz, M ;

Nathrath, W ;

Graeff, H ;

Schwaiger, M .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (17) :1204-1209

[5]

BAGLEY FH, 1978, CANCER, V41, P2154, DOI 10.1002/1097-0142(197806)41:6<2154::AID-CNCR2820410612>3.0.CO

[6]

2-#

[7]

Bender H, 1997, ANTICANCER RES, V17, P1687

[8] Comparison of pharmacokinetic MRI and [18F] fluorodeoxyglucose PET in the diagnosis of breast cancer:: initial experience [J].

Brix, G ;

Henze, M ;

Knopp, MV ;

Lucht, R ;

Doll, J ;

Junkermann, H ;

Hawighorst, H ;

Haberkorn, U .

EUROPEAN RADIOLOGY, 2001, 11 (10) :2058-2070

[9] Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT):: A feasibility study [J].

Ciernik, IF ;

Dizendorf, E ;

Baumert, BG ;

Reiner, B ;

Burger, C ;

Davis, JB ;

Lütolf, UM ;

Steinert, HC ;

Von Schulthess, GK .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (03) :853-863

[10]

Crippa F, 1998, J NUCL MED, V39, P4

← 1 2 3 4 5 →